scispace - formally typeset
M

Maria-Magdalena Balp

Researcher at Novartis

Publications -  59
Citations -  1482

Maria-Magdalena Balp is an academic researcher from Novartis. The author has contributed to research in topics: Medicine & Omalizumab. The author has an hindex of 16, co-authored 46 publications receiving 967 citations.

Papers
More filters
Journal ArticleDOI

A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence.

TL;DR: This review identified few studies that evaluate the statistical association between satisfaction and adherence, compliance, or persistence and suggested that greater treatment satisfaction was associated with better compliance and improved persistence, and with lower regimen complexity or treatment burden.
Journal ArticleDOI

Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

Emmanuel Selvaraj, +132 more
TL;DR: In this paper, the authors evaluated the diagnostic accuracy of non-invasive index tests against histology as the reference standard, in adult patients with non-alcoholic fatty liver disease (NAFLD).
Journal ArticleDOI

The Impact of Chronic Urticaria from the Patient’s Perspective: A Survey in Five European Countries

TL;DR: This research adds to the existing evidence showing significant burden of CSU, and matches and regression models were used to quantify the impact of chronic urticaria on health-related quality of life, self-reported psychological complaints, work and activity impairment, and healthcare use.
Journal ArticleDOI

Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey

TL;DR: Chronic hives substantially affects quality of life, nonwork activities, capacity to work, and health care use, providing further evidence of a high burden of CIU/CSU across multiple health outcomes and unmet need for effective treatment.
Journal ArticleDOI

Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients.

TL;DR: This study assessed the prevalence of chronic urticaria and CSU, and disease management among pediatric patients (0‐17 years), and medicine management among children (0-17 years) in this study.